<SEC-DOCUMENT>0001185185-24-000233.txt : 20240313
<SEC-HEADER>0001185185-24-000233.hdr.sgml : 20240313
<ACCEPTANCE-DATETIME>20240313090058
ACCESSION NUMBER:		0001185185-24-000233
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240312
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240313
DATE AS OF CHANGE:		20240313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IGC Pharma, Inc.
		CENTRAL INDEX KEY:			0001326205
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				202760393
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32830
		FILM NUMBER:		24744701

	BUSINESS ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854
		BUSINESS PHONE:		301-983-0998

	MAIL ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	India Globalization Capital, Inc.
		DATE OF NAME CHANGE:	20050505
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>igcpharma20240311_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:igc="http://www.igcinc.us/20240312" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
	<title>igcpharma20240311_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 3/12/2024 9:46:18 PM -->

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div>
</div><hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/><div>
</div><hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/><div>
</div><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES</b></p><div>

</div><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b>&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p><div>

</div><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-375">8-K</ix:nonNumeric></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">CURRENT REPORT</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-46"><b><span style="text-decoration:underline">March 12, 2024</span></b></ix:nonNumeric></p><div>

</div><p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div style="text-align: center;"><img alt="igc_logo1.jpg" src="igc_logo1.jpg"/></div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-62"><b><span style="text-decoration:underline">IGC PHARMA, INC.</span></b></ix:nonNumeric></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;">(Exact name of registrant as specified in charter)</p>	</td>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	<td style="vertical-align:top;width:18.5%;">&#160;</td>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 2pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-74"><b><span style="text-decoration:underline">Maryland</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-79"><b><span style="text-decoration:underline">001-32830</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:13.9%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 13pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber" id="ixv-84"><b><span style="text-decoration:underline">20-2760393</span></b></ix:nonNumeric></p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 3pt;">(State or other jurisdiction of incorporation)</p>	</td>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;">(Commission File Number)</p>	</td>	<td style="vertical-align:top;width:13.9%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 13pt;">(I.R.S. Employer Identification No.)</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	<td style="vertical-align:top;width:18.5%;">&#160;</td>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-376">10024 Falls Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-377">Potomac</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-378">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-379">20859</ix:nonNumeric></span></b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;">(Address of principal executive offices) (Zip Code)</p>	</td>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	<td style="vertical-align:top;width:18.5%;">&#160;</td>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	</tr>	<tr>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 5pt;"><b><span style="text-decoration:underline">(<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode" id="ixv-380">301</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber" id="ixv-381">983-0998</ix:nonNumeric></span></b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 6pt;">(Registrant&#8217;s telephone number, including area code)</p>	</td>	<td style="vertical-align:top;width:13.9%;">&#160;</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityInformationFormerLegalOrRegisteredName" id="ixv-122"><b>India Globalization Capital, Inc.</b></ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline">4336 Montgomery Ave., Bethesda, MD 20814</span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed since Last Report)</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:middle;width:1.1%;">&#160;</td>	<td style="vertical-align:top;width:3.3%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:WrittenCommunications" id="ixv-382">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>	</td>	</tr>	<tr>	<td style="vertical-align:middle;width:1.1%;">&#160;</td>	<td style="vertical-align:top;width:3.3%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:SolicitingMaterial" id="ixv-383">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>	</td>	</tr>	<tr>	<td style="vertical-align:middle;width:1.1%;">&#160;</td>	<td style="vertical-align:top;width:3.3%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementTenderOffer" id="ixv-384">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>	</td>	</tr>	<tr>	<td style="vertical-align:middle;width:1.1%;">&#160;</td>	<td style="vertical-align:top;width:3.3%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementIssuerTenderOffer" id="ixv-385">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:auto;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>	</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">	<tr>	<td style="vertical-align: top; width: 18.6%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></p>	</td>	<td style="vertical-align: top; width: 9.3%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol(s)</b></p>	</td>	<td style="vertical-align: top; width: 18.6%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></p>	</td>	</tr>	<tr>	<td style="vertical-align: top; width: 18.6%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle" id="ixv-386">Common Stock, $.0001 par value</ix:nonNumeric></p>	</td>	<td style="vertical-align: top; width: 9.3%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol" id="ixv-387">IGC</ix:nonNumeric></p>	</td>	<td style="vertical-align: top; width: 18.6%; border: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-388">NYSE American</ix:nonNumeric></p>	</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (&#167;240.12b-2 of this chapter)</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="ixv-389">&#9744;</ix:nonNumeric>.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 5.02</b></p>
			</td>
			<td style="vertical-align:middle;width:42.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">On March 12, 2024, the Board of Directors (the &#8220;Board&#8221;) of IGC Pharma, Inc. (the &#8220;Company&#8221; or &#8220;IGC&#8221;) appointed Mr. Terry Lierman (&#8220;Mr. Lierman&#8221;) to serve on the Board as a Class B director.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:27pt;">Mr. Lierman will serve as an independent Class B director until the Company&#8217;s 2024 annual meeting of stockholders or upon the election and qualification of successor directors, his earlier death, resignation, or removal. At the 2024 stockholders meeting, the Company plans to nominate him for election, and, if elected, he will serve for three years until the 2027 annual meeting.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:27pt;">Based on the director independence listing standards of the New York Stock Exchange and the Company&#8217;s Corporate Governance Guidelines, the Board affirmatively determined that Mr. Lierman is independent. There is no arrangement or understanding pursuant to which Mr. Lierman is appointed to the Board, and there are no related party transactions between the Company and Mr. Lierman that would require disclosure under Item 404(a) of Regulation S-K.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:27pt;">Mr. Lierman&#8217;s compensation is consistent with the Company&#8217;s standard compensation for non-employee directors. As a new independent director, Mr. Lierman is granted options to buy 150,000 shares of the Company&#8217;s common stock at an exercise price of $0.30 per share with an expiration of 10 years. The vesting schedule of the options is 50,000 vesting immediately, and the remaining 100,000 options vesting in equal installments in 2025 and 2026. In addition, the Company entered into a Board of Directors Agreement with Mr. Lierman in connection with his appointment to the Board, the form of which is filed herewith.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 7.01</b></p>
			</td>
			<td style="vertical-align:middle;width:42.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Regulation FD Disclosure.</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On March 12, 2024, the Company issued a press release announcing Mr. Lierman&#8217;s appointment to the Board as discussed in Item 5.02 of this Current Report on Form 8-K. A copy of this press release is furnished as Exhibit 99.1 and is incorporated by reference herein.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The information contained in this Item 7.01 of this Current Report on Form 8-K, including the Exhibit 99.1 attached hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:1.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01</b></p>
			</td>
			<td style="vertical-align:top;width:19.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits.</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Exhibits.</i></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration:underline">Exhibit No.</span></b></p>
			</td>
			<td style="vertical-align:middle;width:6.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration:underline">Description</span></b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1</p>
			</td>
			<td style="vertical-align:middle;width:6.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_637840.htm" style="-sec-extract:exhibit;">IGC Board of Directors Agreement Form*</a></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">99.1</p>
			</td>
			<td style="vertical-align:middle;width:6.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_637841.htm" style="-sec-extract:exhibit;">Press release issued by IGC Pharma, Inc. on March 12, 2024.*</a></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</p>
			</td>
			<td style="vertical-align:middle;width:6.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (formatted as Inline XBRL)</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">* Filed herewith.&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:1.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:0.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IGC PHARMA, INC.</b></p>
			</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:0.8%;">&#160;</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.1%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:0.7%;">&#160;</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated:&#160;&#160;March 12, 2024</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/&#160;Claudia Grimaldi</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.1%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:&#160;Claudia Grimaldi</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.1%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:&#160;Vice President and PFO</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.1%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:0.7%;">&#160;</td>
			<td style="vertical-align:top;width:0.3%;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-392">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-393">0001326205</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="igc-20240312.xsd" xlink:type="simple"/></ix:references>
<ix:resources><xbrli:context id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEHHD2fdt6+tDg3tfPbVWkvZs9nTrWEB6YDBwuYXkWycIujdy5dN6/tM425+eQXbE939n23SNUPkCHC7SgWPWvssyzwZt+UNNmB7lUmmC9H3NKFczgY1vAV4b2NGxuMYtoA==] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-03-12</xbrli:startDate>
    <xbrli:endDate>2024-03-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_637840.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_637840.htm</title>
	<!-- Generated by ThunderDome Portal - 3/12/2024 12:43:31 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 10.1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Board of Directors Agreement Form</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This Board of Directors Agreement (this &#8220;Agreement&#8221;), dated as of March___, 2024 is between IGC Pharma, Inc., a corporation organized under the laws of Maryland, (&#8220;IGC or the &#8220;Company&#8221;) and&nbsp;<u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u>&nbsp;, an individual, with a principal address at <u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u><u> </u><u>&nbsp;</u> (&#8220;Director&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>BACKGROUND</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:25pt;">IGC desires to have the benefit of Director&#8217;s knowledge and experience, and Director desires to provide services to IGC as provided in this Agreement. Additionally, as of the date hereof, Company and Director shall enter into a separate Indemnification Agreement to the benefit of Director (the &#8220;Indemnification Agreement&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:25pt;"><b>NOW, THEREFORE</b>, in consideration of the promises set forth in this Agreement, IGC and Director hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1. <b>Term.</b> This Agreement shall continue for a period of ___ year(s) from the Effective Date and shall continue thereafter for as long as Director is elected as a member of the Board of Directors of Company (the &#8220;Board&#8221;) or as otherwise terminated pursuant to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2. <b>Position and Responsibilities.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(a) Position. Company hereby retains Director to serve as a member of the Board as well as any committees of the Board, as elected by the Board from time to time. Director shall perform such duties and responsibilities as are normally related to such position in accordance with Company&#8217;s bylaws, as amended, and applicable law (the &#8220;Services&#8221;), and Director hereby agrees to use his best efforts to provide the Services. Director shall not allow any other person or entity to perform any of the Services for or instead of Director. Director shall comply with the statutes, rules, regulations and orders of any governmental or quasi-governmental authority, which are applicable to the performance of the Services, and Company&#8217;s rules, regulations, and practices as they may from time-to-time be adopted or modified.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(b) Other Activities. Director may be employed by another company, may serve on other boards of directors or advisory boards, and may engage in any other business activity (whether or not pursued for pecuniary advantage), as long as such outside activities do not violate Director&#8217;s obligations under this Agreement or Director&#8217;s fiduciary obligations to the shareholders. The ownership of less than a 10% interest in an entity, by itself, shall not constitute a violation of this duty. Except as disclosed in writing by Director to Company, Director represents that, to the best of his knowledge, Director has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, and Director agrees to use his best efforts to avoid or minimize any such conflict and agrees not to enter into any agreement or obligation that could create such a conflict, without the approval of a majority of the Board of Directors. If, at any time, Director is required to make any disclosure or take any action that may conflict with any of the provisions of this Agreement, Director will promptly notify the Chief Executive Officer or the Board of Directors of such obligation, prior to making such disclosure or taking such action.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(c) No Conflict. Director is not currently engaging in any activity that creates an actual conflict of interest with Company, regardless of whether such activity is prohibited by Company&#8217;s conflict of interest guidelines or this Agreement, and Director agrees to notify the Board before engaging in any activity that creates a potential conflict of interest with Company. In the event Director engages in any activity that creates an actual conflict of interest with Company without the prior written consent of the Board, a majority of the disinterested members of the Board may vote to terminate this Agreement, remove Director from the Board and immediately cease any compensation under Section 3(a) and 3(b) below to Director; <u>provided, however,</u> Director shall continue to be entitled to expense reimbursement for any expenses incurred prior to the termination of this Agreement and in accordance with Section 3(c) below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">3. <b>Compensation and Benefits.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(a) Director&#8217;s Equity Grant. The initial grant shall be a grant of Restricted Stock Unit (RSU) or Options of a certain amount of shares, governed by a separate RSU/Option agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(b) Expenses. The Company shall reimburse Director for all reasonable business expenses incurred in the performance of his duties hereunder in accordance with Company&#8217;s expense reimbursement guidelines. Such reimbursement shall include the cost of coach airfare and one night of hotel stay for any board meeting wherein the Company specifically requests that Director shall attend such meeting in person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(c) Records. Director shall have access to books and records of Company, as necessary to enable Director to fulfill his obligations as a Director of Company as required by Maryland law. Director shall give Company reasonable notice for any inspection of books and records that Director requests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(d) Insurance. The Company shall at all times during the term of this Agreement maintain industry standard directors' and officers' liability insurance from a reputable insurance company which shall cover all members of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4. <b>Termination.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(a) Right to Terminate. At any time, Director may be removed as a director (i) as provided in Company&#8217;s Certificate of Incorporation, as amended, bylaws, as amended, and applicable law or (ii) immediately for Cause. At any time, Director may resign as a director as provided in Company&#8217;s Certificate of Incorporation, as amended, bylaws, as amended, and applicable law. Notwithstanding anything to the contrary contained in or arising from this Agreement or any statements, policies, or practices of Company, neither Director nor Company shall be required to provide any advance notice or any reason or cause for termination of Director, except as provided in Company&#8217;s Certificate of Incorporation, as amended, bylaws, as amended, and applicable law. For purposes of this Agreement, Cause means: (A) any action which might be reasonably considered to be immoral, deceptive, scandalous, or obscene, (B) any action which could reasonably injure, tarnish, damage or otherwise negatively affect the reputation of the Company, (C) commission at any time of any act or omission that results in a conviction or plea of no contest for any felony or crime involving moral turpitude, (D) commission at any time of any act of fraud, embezzlement, willful misappropriation of material Employer property, or willful and material misconduct, or (E) any violation of Director&#8217;s a duty of loyalty, or a material violation of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(b) Effect of Termination as Director. Upon a termination of Director&#8217;s status as a Director, this Agreement shall terminate. Company shall pay to Director all compensation and benefits to which Director is entitled up through the date of termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">5. <b>Termination Obligations.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(a) Director agrees that all property, including, without limitation, all equipment, tangible proprietary information, documents, records, notes, contracts, and computer-generated materials provided to or prepared by Director incident to his services belong to Company and shall be promptly returned at the request of Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(b) Upon termination of this Agreement, Director agrees that following any termination of this Agreement, he shall cooperate with Company in the winding up or transferring to other directors of any pending work and shall also cooperate with Company (to the extent allowed by law, and at Company&#8217;s expense) in the defense of any action brought by any third party against Company that relates to the Services.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">(c) The Company and Director agree that their obligations under this Section, as well as Sections 4(b), 5(a), 5(b), 6, 7, 8, 9, 13 and 14 shall survive the termination of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">6. <b>Nondisclosure Obligations.</b> Director shall maintain in confidence and shall not, directly or indirectly, disclose or use, either during or after the term of this Agreement, any Proprietary Information (as defined below), confidential information, or trade secrets belonging to Company, whether or not it is in written or permanent form, except to the extent necessary to perform the Services, as required by a lawful government order or subpoena, or as authorized in writing by Company. These nondisclosure obligations also apply to Proprietary Information belonging to customers and suppliers of Company, and other third parties, learned by Director as a result of performing the Services. &#8220;Proprietary Information&#8221; means all information pertaining in any manner to the business of Company, unless (i) the information is or becomes publicly known through lawful means; (ii) the information was part of Director&#8217;s general knowledge prior to his relationship with Company; or (iii) the information is disclosed to Director without restriction by a third party who rightfully possesses the information and did not learn of it from Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">7. <b>Non-Disparagement.</b> Director agrees he shall not knowingly disparage Company, its subsidiaries or its officers, directors, employees or agents in any manner that could be harmful to it or them or its or their business, business reputation or personal reputation. Company agrees it shall instruct its officers, directors, employees and agents not to knowingly disparage Director in any manner that could be harmful to his business or personal reputation. This paragraph will not be violated by statements from either party that are truthful, complete and made in good faith in required response to a legal right, legal process or governmental inquiry. Nothing in this Agreement is intended to limit in any way Director&#8217;s right or ability to file a claim with the Securities and Exchange Commission (the &#8220;SEC&#8221;) or comparable state or local agencies.&nbsp; These agencies have the authority to carry out their statutory duties by investigating a claim, issuing a determination, filing a lawsuit in Federal or state court in their own name, or taking any other action authorized under these statutes.&nbsp; Director retains the right to participate in such any action<b>.</b>&nbsp; Director retains the right to communicate with the SEC and comparable state or local agencies and such communication can be initiated by Director or in response to the government and is not limited by any non-disparagement obligation under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">8.<b> Dispute Resolution. </b>The parties agree that any dispute between Director (and his attorneys, successors, and assigns) and Company (and its affiliates, shareholders, directors, officers, employees, members, agents, successors, attorneys, and assigns) relating to the Services or the termination of those Services shall be attempted to be resolved amicably, and if not possible, then through mediation and later through arbitration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">9. <b>Cooperation.</b> During the term of this Agreement and subsequent to termination of this Agreement, Director agrees that, upon written request of Company, and he will make himself reasonably available, taking into account his other business and personal commitments, to cooperate with Company, its subsidiaries and affiliates and any of their officers, directors, shareholders, or employees in connection with any investigation or review by Company or any federal, state or local regulatory, quasi-regulatory or self-governing authority as any such investigation or review relates to events or occurrences that transpired while Director was on the Board and in respect of which Director has knowledge (collectively, &#8220;Cooperation&#8221;).&nbsp; Director&#8217;s Cooperation shall include but not be limited to being available to meet with officers or employees of Company and/or Company&#8217;s counsel at mutually convenient times and locations, executing accurate and truthful documents and taking such other actions as may reasonably be requested by Company and/or Company&#8217;s counsel to effectuate the foregoing.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">10. <b>Entire Agreement.</b> This Agreement and the Indemnification Agreement are intended to be the final, complete, and exclusive statement of the terms of Director&#8217;s relationship solely with respect to his position as a Board with Company. This Agreement entirely supersedes and may not be contradicted by evidence of any prior or contemporaneous statements or agreements pertaining to Director&#8217;s relationship with Company, except for the Indemnification Agreement and Option Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">11. <b>Amendments; Waivers.</b> This Agreement may not be amended except by a writing signed by Director and by a duly authorized representative of the Company other than Director. Failure to exercise any right under this Agreement shall not constitute a waiver of such right.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">12. <b>Assignment.</b> Director agrees that Director will not assign any rights or obligations under this Agreement, with the exception of Director&#8217;s ability to assign rights with respect to the Securities. Nothing in this Agreement shall prevent the consolidation, merger or sale of Company or a sale of all or substantially all of its assets.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">13. <b>Severability.</b> If any provision of this Agreement shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. In the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall reduce the time period or scope to the maximum time period or scope permitted by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">14. <b>Governing Law.</b> This Agreement shall be governed by and construed in accordance with the laws of the State of Maryland.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">15. <b>Interpretation.</b> This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Captions are used for reference purposes only and should be ignored in the interpretation of the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">16. <b>Binding Agreement.</b> Each party represents and warrants to the other that the person(s) signing this Agreement below has authority to bind the party to this Agreement and that this Agreement will legally bind both Company and Director. This Agreement will be binding upon and benefit the parties and their heirs, administrators, executors, successors and permitted assigns. To the extent that the practices, policies, or procedures of Company, now or in the future, are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">17. <b>Director Acknowledgment.</b> Director acknowledges Director has had the opportunity to consult legal counsel concerning this Agreement, that Director has read and understands the Agreement, that Director is fully aware of its legal effect, and that Director has entered into it freely based on his own judgment and not on any representations or promises other than those contained in this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">18. <b>Counterparts.</b> This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;"><b>IN WITNESS WHEREOF</b>, this Board of Directors Agreement is executed as of the date first referenced above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:3.4%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.3%;">&nbsp;</td>
			<td style="vertical-align:middle;width:19.2%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.3%;">&nbsp;</td>
			<td style="vertical-align:middle;width:0.6%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.3%;">&nbsp;</td>
			<td style="vertical-align:middle;width:3.4%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1.9%;">&nbsp;</td>
			<td style="vertical-align:middle;width:17%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC PHARMA, INC</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;DIRECTOR:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:1.9%;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 5pt;text-indent:-5pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name:</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:17%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 2pt;text-indent:-2pt;">Title:</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1.9%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:17%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_637841.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_637841.htm</title>
	<!-- Generated by ThunderDome Portal - 3/13/2024 12:59:45 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="ex_637841img001.jpg" src="ex_637841img001.jpg" style="width:164;height:96;"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;margin:0pt;"><b>IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer</b>&#8217;<b>s Pipeline</b><br>
<br>
Potomac, MD, March 12, 2024 &#8211; IGC Pharma, Inc. (&#8220;IGC Pharma,&#8221; &#8220;IGC,&#8221; or the &#8220;Company&#8221;) (NYSE American: IGC) today announced that it has appointed Terry Lierman as an independent director to its board of directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Lierman is currently Co-Chair of the Board of Advisors at the Institute of Human Virology (IHV), a center in the U.S. focused on accelerating the discovery of diagnostics and therapeutics for deadly viral and immune disorders and a member of the Board of Visitors at the La Follette School of Public Affairs at the University of Wisconsin, his alma mater. Terry founded the Children&#8217;s Research Institute, one of America's top children&#8217;s research programs, the Pancreatic Cancer Action Network (PanCAN), and the National Organization on Fetal Alcohol Syndrome (NOFAS). In addition, from 1987 to 1999, he served as a director/trustee of the NY Life-Mainstay Funds. His distinguished career includes serving at the National Institutes of Health (NIH), as the chief administrator for drug research and development at the National Cancer Institute (NCI), and as the Staff Director for the Committee on Appropriations at the U.S. Senate and the Chief of Staff and White House liaison to the U.S. House of Representative&#8217;s Majority Leader.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda, CEO of IGC Pharma, commented, &#8220;With his track record of execution and extensive experience in health care, Mr. Lierman will undoubtedly bring invaluable insights and strategic guidance to IGC Pharma. His appointment is pivotal for our Company as we advance our Phase 2 trial investigating IGC- AD1 as a treatment for agitation in dementia in Alzheimer&#8217;s and prepare our second AD candidate, TGR-63, for a Phase 1 clinical trial. We are eager to leverage Mr. Lierman&#8217;s expertise as we continue our mission to develop innovative therapeutics to address critical unmet medical needs.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Terry Lierman stated, &#8220;I am honored to be part of a company developing non-invasive solutions to address the challenges of Alzheimer&#8217;s disease and related central nervous system disorders. I am deeply impressed by IGC Pharma&#8217;s commitment to advancing research and development efforts, as evidenced by the ongoing Phase 2 trial of IGC-AD1 for agitation in Alzheimer&#8217;s disease, the preclinical analysis of TGR-63, and the Company&#8217;s artificial intelligence (AI) initiatives. The Company's dedication to improving the quality of life for millions affected by Alzheimer&#8217;s aligns perfectly with my lifelong passion for advancing healthcare initiatives. I look forward to collaborating with the talented team at IGC Pharma to drive forward the mission of bringing transformative therapies to patients in need.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About IGC Pharma Inc. (IGC):</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Pharma Inc. (IGC) is at the forefront of the fight against Alzheimer's disease, developing innovative solutions to address this devastating illness. The company's mission is to transform the landscape of Alzheimer's treatment with a robust pipeline of five promising drug candidates.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC-AD1 and LMP target the hallmarks of Alzheimer's disease, including neuroinflammation, A&#946; plaques, and neurofibrillary tangles. IGC-AD1 is currently undergoing a Phase 2b clinical trial for agitation in dementia associated with Alzheimer's (clinicaltrials.gov, CT05543681). TGR-63 disrupts the progression of Alzheimer's by targeting A&#946; plaques. IGC-M3, currently in preclinical development, aims to inhibit the aggregation of A&#946; plaques, potentially impacting early-stage Alzheimer's. IGC-1C, also in preclinical stages, targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer's therapy. In addition to its drug development pipeline, IGC Pharma is actively leveraging Artificial Intelligence (AI) for Alzheimer's research. Their AI projects encompass various areas, including clinical trial optimization and early detection of Alzheimer's.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Forward-Looking Statements:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">This press release contains forward-looking statements. These forward-looking statements are based largely on IGC Pharma&#8217;s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma&#8217;s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company&#8217;s failure or inability to commercialize one or more of the Company&#8217;s products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA&#8217;s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma&#8217;s U.S. Securities and Exchange Commission ("SEC") filings. IGC Pharma incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on July 7, 2023, and Quarterly Report on Form 10-Q filed with the SEC on February 14, 2024, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Contact:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investors</b><br>
IMS Investor Relations<br>
Rosalyn Christian<br>
igc@imsinvestorrelations.com<br>
(203) 972-9200</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Media</b><br>
JVPRNY<br>
Janet Vasquez<br>
jvasquez@jvprny.com<br>
(212) 645-5498</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>igc-20240312.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 12 22:06:33 UTC 2024 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.igcinc.us/20240312" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:igc="http://www.igcinc.us/20240312" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20240312_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20240312_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20240312_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEHHD2fdt6+tDg3tfPbVWkvZs9nTrWEB6YDBwuYXkWycIujdy5dN6/tM425+eQXbE939n23SNUPkCHC7SgWPWvssyzwZt+UNNmDExHbar0D4XBj6BvLKDD5gXXvPC4W89YA==] CSR-->
      <link:roleType roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>igc-20240312_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 12 22:06:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="igc-20240312.xsd#DocumentAndEntityInformation" roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.igcinc.us/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEHHD2fdt6+tDg3tfPbVWkvZs9nTrWEB6YDBwuYXkWycIujdy5dN6/tM425+eQXbE939n23SNUPkCHC7SgWPWvssyzwZt+UNNmBWMyNZXdsHqX56A9b8vdtUaFtuulM662A==] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="23" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>igc-20240312_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 12 22:06:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEHHD2fdt6+tDg3tfPbVWkvZs9nTrWEB6YDBwuYXkWycIujdy5dN6/tM425+eQXbE939n23SNUPkCHC7SgWPWvssyzwZt+UNNmEO5TMjx2hM3OAZGvRxRTt8=] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl0" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl0" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl0" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>igc-20240312_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 12 22:06:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="igc-20240312.xsd#DocumentAndEntityInformation" roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.igcinc.us/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="igc-20240312.xsd#igc_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAKD9Z7zGpK2qQstFsfCu8xSrtW9H2+v0Xv0rh9+KH/Pz8D0bXTVzCQTQCC6nPug5x3Q1UInPHgbEHHD2fdt6+tDg3tfPbVWkvZs9nTrWEB6YDBwuYXkWycIujdy5dN6/tM425+eQXbE939n23SNUPkCHC7SgWPWvssyzwZt+UNNmDExHbar0D4XAUwx9EmlP2zPxNesxi5Oeg==] CSR-->
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex_637841img001.jpg
<TEXT>
begin 644 ex_637841img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !@ *0# 2(  A$! Q$!_\0
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M0 4444 %%%% $-S.MM:S7#?=B1G/T S7R]=7,E[=S7<I)DGD:1B?4G-?2WB
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MZY^P/?K>>4WDF2XW*'Q\N1CD9K*C.G2A%2>^_IM8&FV>H6UQ%=VL5S X>&5
MZ,.C*1D&BO.OAKJ6N:1X-@TS7-!U1+BTD:*,B G,?!7\LD?A17'.DXR:6I29
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>igc_logo1.jpg
<TEXT>
begin 644 igc_logo1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !* &L# 2(  A$! Q$!_\0
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2;5QLQ)6+'6BBBN,H**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139854206501856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 12, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IGC PHARMA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IGC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 12,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2760393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10024 Falls Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Potomac<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">983-0998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">India Globalization Capital, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MS ^WG,'RV@O@][52YC"P;^7EGRKC?P%02P,$%     @ '$AM6)^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( !Q(;5@'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ '$AM6!,&.%7O    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ '$AM6)E<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  <
M2&U8S3@+L7L$  !@$0  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ '$AM6)^@&_"Q @  X@P   T
M         ( !OPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  <2&U8EXJ[
M',     3 @  "P              @ &;#P  7W)E;',O+G)E;'-02P$"% ,4
M    "  <2&U8.JJBYT !   \ @  #P              @ &$$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ '$AM6"0>FZ*M    ^ $  !H
M     ( !\1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ '$AM6&60>9(9 0  SP,  !,              ( !UA(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  (!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="igcpharma20240311_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.igcinc.us/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>igc-20240312.xsd</File>
    <File>igc-20240312_def.xml</File>
    <File>igc-20240312_lab.xml</File>
    <File>igc-20240312_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="igcpharma20240311_8k.htm">igcpharma20240311_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>igc_logo1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "igcpharma20240311_8k.htm": {
   "nsprefix": "igc",
   "nsuri": "http://www.igcinc.us/20240312",
   "dts": {
    "schema": {
     "local": [
      "igc-20240312.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "igc-20240312_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "igc-20240312_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "igc-20240312_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "igcpharma20240311_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.igcinc.us/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "igcpharma20240311_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "igcpharma20240311_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "igc_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.igcinc.us/20240312",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information, Former Legal or Registered Name",
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001185185-24-000233-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001185185-24-000233-xbrl.zip
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MQ2N5MJ66,#9, O2 X?:2V J3<C"M14#EAT1]DAD:ZT8;U".K7HB9 #$=S_M
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MM:'_;UTA,@?\?$V%>/K.JA<V0Y,&0\"N>_K]PZ'@$F(@U4<!5N/)?'H4XZ3
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MT_MOY)HGRQ6^B!?&AG&?Y>&8\A[BL'H;\-F?$M?W'/PO%^=_2(M\ #SP5['
M.TW='V:!N]K!?YRXE^!KWBIBV\BKVR4BPO__JX%WM/_5K9:7__U3#/"^6+'_
M\+]"1@)UCX;4/2+J7N.[-3Y)T(<\[5_%I??@)_KG_VC@]*\+ /YP_OIZOPN9
MK0WI_5]#=3Y2!;_@7T8^.[U/?^#Y?U!+ P04    "  <2&U8V^'9ZNP,  !I
M*   #0   &5X7S8S-S@T,2YH=&WE6FU3&T<2_GS^%7.DSH8J24@8OX P%5F
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MUI0EIY%+O4),0FVUI7'_I@*82T+([MPQI(GKPQ5 )(%"'V&_D$K;,]TL&GF
M".&W#=.I1R+IW]!U4Q/;GDMA;C[]8#\QI771LBQ-[N:F*=W'/-]9$E]ZIKO<
M<A)%;=AN=67-5K:<8\!6]NN42]IB,S?EF1]9B8"1W87@&YK@*Q"&JINJ65PG
M@@Z4#V'*7.Q#Y1*< "#$=S&.F<OX:14GZ$2<(KF<) B/XLOE$E\4I:SFY7^
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MG"9Y$,3=+]HV[_/?CR*YFK?:ZI= *OX?4$L#!!0    ( !Q(;5@TV8)X+ 8
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MW'X2WCS-F7RT>$<DE?@?4$L#!!0    ( !Q(;5A.SWR-Y 4  %,M   4
M:6=C+3(P,C0P,S$R7W!R92YX;6S56EUSXC84?>^O<.E+.QEB, '6F9 =UI#
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MY_V,0X%%Z7.H[Q\P?_SO4$L#!!0    ( !Q(;5BSH=92,!0  %]X   8
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M6$+3!)I D=MVB" J76GL.F:R_PT$$;3_MD1C@F:R;$N^EX0Z3@"> @0_TDT
MN@N,Q8>N#9I8RFLP#LG (C$%3X)\@E'S@FT<%I@F$P(&1$N++$$77%TBA<>,
M^L,L>"D"6%D.RRJO9>1"L)\C#5^N(J%*P1#"EDUN@HQM<(Z04QQW!/X.N%Q#
M/I(.4@1F%N&453.AHP7@L"3RL+,_]!@C>!]5)# %,)07,/.C,-H^11<RI'C,
M1',.,QFQP8E-NY2AOXA@O'?!WY7IG+G[B/RRC &;X1T,1HY<,%CHM<*/ 3BG
M6+PEDFJ+@M*7A6T39L^ E< E&\D8T1]2GR2E0];^Q/( :@<B4(9/'9=0ST.
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M&$+Q^(S_ NRN\5!VM[J^W4U 67T , _CDQ)YW58YIJB$0]T@?EI?=3/)VE0
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M4KZA?Z01PK_5QT/EYT;K_P]02P$"% ,4    "  <2&U8X)% >\(9  #G>0
M#0              @ $     97A?-C,W.#0P+FAT;5!+ 0(4 Q0    ( !Q(
M;5C;X=GJ[ P  &DH   -              "  >T9  !E>%\V,S<X-#$N:'1M
M4$L! A0#%     @ '$AM6.#U08U1!   T@P  !               ( !!"<
M &EG8RTR,#(T,#,Q,BYX<V102P$"% ,4    "  <2&U8--F">"P&  #:*P
M%               @ &#*P  :6=C+3(P,C0P,S$R7V1E9BYX;6Q02P$"% ,4
M    "  <2&U8.2-A>RL(  "B4P  %               @ 'A,0  :6=C+3(P
M,C0P,S$R7VQA8BYX;6Q02P$"% ,4    "  <2&U83L]\C>0%  !3+0  %
M            @ $^.@  :6=C+3(P,C0P,S$R7W!R92YX;6Q02P$"% ,4
M"  <2&U8SR]!O.L)  !Q"@  #0              @ %40   :6=C7VQO9V\Q
M+FIP9U!+ 0(4 Q0    ( !Q(;5BSH=92,!0  %]X   8              "
M 6I*  !I9V-P:&%R;6$R,#(T,#,Q,5\X:RYH=&U02P4&      @ " #[ 0
&T%X

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>igcpharma20240311_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="igc-20240312.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2024-03-12</startDate>
            <endDate>2024-03-12</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0" id="ixv-375">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-46">2024-03-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-62">IGC PHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-74">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c0" id="ixv-79">001-32830</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-84">20-2760393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-376">10024 Falls Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-377">Potomac</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-378">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-379">20859</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-380">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-381">983-0998</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="c0" id="ixv-122">India Globalization Capital, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="c0" id="ixv-382">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c0" id="ixv-383">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c0" id="ixv-384">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c0" id="ixv-385">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c0" id="ixv-386">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-387">IGC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-388">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-389">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentFlag contextRef="c0" id="ixv-392">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-393">0001326205</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
